System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Howard C Herrmann is an expert in Cardiology at Hospital of the University of Pennsylvania (United States). As of October 2026, ScienceLeadR ranks Howard C Herrmann in the top 1% of experts worldwide for Ventricular Outflow Obstruction and Aortic Valve Disease. Howard C Herrmann has authored 605 publications, the most recent in 2026, and is an investigator in 28 clinical trials, 2 of them ongoing. SLR score: 2,021 (community average: 125). How the SLR is computed.

LeadR Profile

Howard C Herrmann Hospital of the University of Pennsylvania United States
2 021 ScienceLeadR Reputation 2021

Unlock

Register Login
Network Map

Cardiology

Subspecialties: Thoracic And Cardiovascular Surgery - Public Health - Surgery

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2000 - 2026
Source: PubMed

University of Pennsylvania

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 605

Citations

Citations: 70 640 1st author: 27 Last author: 50 Unique author: 178

Main journals

Journal watch 160
J Am Coll Cardiol 107
JACC Cardiovasc Interv 44
Catheter Cardiovasc Interv 30
Circulation 27

Best Journals

N Engl J Med 24
Circulation 4
JAMA 4

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
The current and future in transcatheter treatment of aortic stenosis: from the 'beyond the guidelines' session at cardiovascular research technologies 2026.
PMID 42562719 — constriction, pathologic, aortic valve stenosis, aortic valve, transcatheter aortic valve replacement, research, therapeutics, physical exertion, surgical aortic valve replacement		Cardiovasc Revasc Med20260
Procedural Strategies for Optimal Transcatheter Aortic Valve Replacement: An International Position Statement.
PMID 42442887 — aortic valve, transcatheter aortic valve replacement		JACC Cardiovasc Interv20261
Seven-Year Valve Durability With Transcatheter or Surgical Aortic Valve Replacement: An Ad Hoc Analysis of the PARTNER 3 Randomized Clinical Trial.
PMID 42340728 — constriction, pathologic, aortic valve stenosis, incidence, cardiovascular diseases, endocarditis, aortic valve, transcatheter aortic valve replacement, thrombosis, surgical aortic valve replacement		JAMA Cardiol20266
Impact of Adverse Events on Costs and Length of Stay Following Transcatheter Tricuspid Valve Replacement.
PMID 42325408 — tricuspid valve, drug-related side effects and adverse reactions, length of stay, therapeutics, tricuspid valve insufficiency		Struct Heart20260
Outcomes of Self-Expanding Versus Balloon-Expandable Transcatheter Aortic Valves in Patients With Reduced Left Ventricular Ejection Fraction: A Meta-Analysis of Observational Studies.
PMID 42199515 — mortality, aortic valve, transcatheter aortic valve replacement		Struct Heart20260

Clinical Studies 28

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

N/A 23
Phase 3 4
Phase 2/Phase 3 1

By status:

Completed 12
Active not recruiting 9
Unknown 3
Recruiting 2
Terminated 2

By type:

Interventional 23
Observational 5

By Monocentric/Multicentric:

monocentric 8
multicentric2to4 2
multicentric5to9 0
multicentricup10 18

Main Topics

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
SMall Annuli Randomized To Evolut or SAPIEN Trial
NCT04722250 — constriction, pathologic, aortic valve stenosis, stress, physiological, aortic valve, transcatheter aortic valve replacement, therapeutics		N/AActive not recruiting2021
TRISCEND II Pivotal Trial
NCT04482062 — heart valve diseases, safety, heart failure, heart, cardiovascular diseases, tricuspid valve, therapeutics, tricuspid valve insufficiency, heart valves		N/AActive not recruiting2021

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS